The Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact
|
|
- Evangeline Pearson
- 6 years ago
- Views:
Transcription
1 The Newcastle upon Tyne Hospitals NHS Foundation Trust Code of Practice for Wound Care Company Representatives and Staff with whom they interact Version No.: 1.1 Effective From: 8 th January 2015 Expiry Date: 8 th January 2018 Date Ratified: 5 th January 2015 Ratified By: 1 Introduction Wound Formulary Review Group This policy establishes the activities of wound care company representatives within the operational and managerial framework of the Newcastle-upon-Tyne Hospitals NHS Foundation Trust including both primary and secondary care settings. This policy supports the Trust s values by ensuring the safest and highest quality healthcare is provided for patients in our care and by facilitating continuous improvement in the most cost-effective way in the provision of wound care (products). 2 Scope This policy applies to all wound care company representatives or those supplying products to prevent wounds e.g. pressure redistributing equipment who are visiting the Trust and any Trust staff members with whom they interact. 3 Aims This policy describes the code to which the representatives must work, the role of the Tissue Viability Team and the role of the Wound Formulary Review Group. 4 Definitions Wound Care is defined in this policy as products used in the management of wounds, wound diagnostics or in the prevention of pressure ulcers 5 The Code This Code of Practice is based on the Code of Practice for Pharmaceutical Representatives but is simplified to reflect the pertinent areas which are applicable to wound care. Promotional activities for products must be consistent with policies agreed by the Trust Drug and Therapeutic Panel as set out in the North of Tyne Formulary. Page 1 of 4
2 5.1 Company representatives should conduct themselves in a professional manner, appropriate to the provision of information on and selling of wound care products in accordance to their own regulatory code All company representatives visiting the Trust for the first time must report to either the Tissue Viability Team or Supplies Department via an arranged appointment. A copy of this Code of Practice will be supplied and any further relevant information about relevant Trust policies and procedures. 5.3 Company representatives should wear an identification badge which should display the individual s name, photographic identification and the company s name/logo. In secondary care- representatives will need to collect a Visitor badge from the main receptions prior to visiting any wards. In primary care, the company identification badge will suffice. 5.4 Company representatives must not enter wards and other Trust premises without prior invitation of a senior member of medical/nursing staff. Any proposed activities must be discussed with the Tissue Viability Team first. 5.5 Company representatives entering clinical areas must comply with Trust policies and procedures, particularly those relating to infection control and patient confidentiality 5.6 Company representatives must send regular updates of activities via to the Tissue Viability Team in order to keep a record of such within the Organisation. 5.7 Product samples must not be left with medical, nursing or allied professionals unless their use has been specifically approved by the Tissue Viability Team or Wound Formulary Review Group. 5.8 All activities including the provision of hospitality and gifts must conform to the professional code of conduct as outlined at Gifts or donations must not be offered or given as an inducement to prescribe, supply, administer or buy a product. 5.9 The Wound Formulary Review Group may request an evaluation of a new product. In this case, products must be purchased by each Directorate. Tissue Viability will organise a supply via a) Pharmacy if they contain active ingredients b) Supply Chain if they are not Pharmacy products In community, these products will be prescribed via FP10 by the Tissue Viability Team. Page 2 of 4
3 5.10 Any samples of consumable products provided for evaluation purposes must meet all appropriate international, national or NHS standards (e.g. CE marking) and be provided with full user instructions and training as necessary Representatives not complying with this policy may be barred from Trust sites The promotion of Non-Formulary wound care products is not allowed. 6 Duties (Roles and responsibilities) 6.1 Role of the Wound Formulary Review Group The Newcastle-upon-Tyne Hospitals NHS Foundation Trust Wound Formulary Review Group exists to promote safe and cost-effective use of wound care products within the Newcastle-upon-Tyne Hospitals NHS Foundation Trust (acute and community settings). This group is established to ensure wound care products for inclusion in the Wound Formulary are evidence-based and adequate for clinical use. Disseminate best practice: it is the responsibility of each member to communicate changes and/or decisions to their directorates. Monitor the development of appropriate evidence based assessment criteria for the selection of wound care products 6.2 Role of the Tissue Viability Service The Tissue Viability Team is central to the development of the Wound Formulary and works in conjunction with the Wound Formulary Review Group Representatives will be seen by advance appointment only Tissue Viability and associated wound care specialists may wish to see representatives for information on new products, new indications for existing products or for discussion of major commercial consideration including training opportunities for staff across the Trust (acute and community settings). 7 Training Staff engaged with the structure outlined in this policy should be familiar with its contents. 8 Equality and Diversity The Trust is committed to ensuring that, as far as is reasonably practicable, the way we provide services to the public and the way we treat our staff reflects their individual needs and does not discriminate against individuals or groups on any grounds. This document has been appropriately assessed. Page 3 of 4
4 9 Monitoring compliance Standard / process / issue The policy will be monitored by the Wound Formulary Review Group Monitoring and audit Method By Committee Frequency Areas of noncompliance will be managed by this group Wound Formulary Review Group Annually 10 Consultation and review This policy was developed in conjunction with the Wound Formulary Review Group. It will be reviewed in three years or earlier if there is an identified need to do so. 11 Implementation (including raising awareness) This policy has been circulated to Tissue Viability Team members and associated Wound Care Specialists, Tissue Viability Link Nurses, members of the Wound Formulary Review Group and members of Medicines Management Team/practice pharmacists. It will be distributed to all companies currently represented on the Wound Formulary and any new representatives that meet with the Tissue Viability Team. 12 References Nil 13 Associated documentation Nil Page 4 of 4
5 The Newcastle upon Tyne Hospitals NHS Foundation Trust Equality Analysis Form A This form must be completed and attached to any procedural document when submitted to the appropriate committee for consideration and approval. PART 1 1. Assessment Date: 06/01/ Name of policy / strategy / service: Code of Practice for Wound Care Company Representatives and Staff with whom they interact 3. Name and designation of Author: Helen Stevens Nurse Specialist (Tissue Viability) 4. Names & designations of those involved in the impact analysis screening process: Fania Pagnamenta (Nurse Consultant Tissue Viability), Frances Blackburn(Head of Nursing Freeman), Matthew Lowery (Senior Clinical Pharmacist) 5. Is this a: Policy X Strategy Service Is this: New Revised X Who is affected Employees X Service Users Wider Community 6. What are the main aims, objectives of the policy, strategy, or service and the intended outcomes? (These can be cut and pasted from your policy) This policy establishes the activities of wound care company representatives within the operational and managerial framework of the Newcastle-upon-Tyne Hospitals NHS Foundation Trust including both primary and secondary care settings. This policy supports the Trust s values by ensuring the safest and highest quality healthcare is provided for patients in our care and by facilitating continuous improvement in the most cost-effective way in the provision of wound care (products). 7. Does this policy, strategy, or service have any equality implications? Yes No X If No, state reasons and the information used to make this decision, please refer to paragraph 2.3 of the Equality Analysis Guidance before providing reasons: It is directed at organisation procedures with no direct impact on service users
6 8. Summary of evidence related to protected characteristics Protected Characteristic Race / Ethnic origin (including gypsies and travellers) Sex (male/ female) Religion and Belief Sexual orientation including lesbian, gay and bisexual people Age Disability learning difficulties, physical disability, sensory impairment and mental health. Consider the needs of carers in this section Gender Re-assignment Marriage and Civil Partnership Maternity / Pregnancy Evidence, i.e. What evidence do you have that the Trust is meeting the needs of people in various protected Groups Does evidence/engagement highlight areas of direct or indirect discrimination? If yes describe steps to be taken to address (by whom, completion date and review date) Does the evidence highlight any areas to advance opportunities or foster good relations. If yes what steps will be taken? (by whom, completion date and review date) 9. Are there any gaps in the evidence outlined above? If yes how will these be rectified? N/A 10. Engagement has taken place with people who have protected characteristics and will continue through the Equality Delivery System and the Equality Diversity and Human Rights Group. Please note you may require further engagement in respect of any significant changes to policies, new developments and or changes to service delivery. In such circumstances please contact the Equality and Diversity Lead or the Involvement and Equalities Officer. Do you require further engagement? Yes No 11. Could the policy, strategy or service have a negative impact on human rights? (E.g. the right to respect for private and family life, the right to a fair hearing and the right to education? No
7 PART 2 Name: Helen Stevens Date of completion: (If any reader of this procedural document identifies a potential discriminatory impact that has not been identified, please refer to the Policy Author identified above, together with any suggestions for action required to avoid/reduce the impact.)
The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Access to Drugs Policy Version No.: 3.0 Effective From: 25 January 2016 Expiry Date: 25 January 2019 Date Ratified: 4 November 2015 Ratified By: Medicines
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Version No: 5.0 Effective From: 7 September 2017 Expiry Date: 31 August 2018 Date Ratified: 30 August 2017 Ratified By: Executive Team 1 Introduction
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage
The Newcastle upon Tyne Hospitals NHS Foundation Trust Strong Potassium Solutions Safe Handling and Storage Version : 5.3 Effective From: 19 January 2016 Expiry Date: 19 January 2019 Date Ratified: 14
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines
The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for registration and supply of prophylaxis to the immediate household contacts of patients admitted with meningococcal disease Version.:
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Use of Patients Own Drugs (PODs)
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Use of Patients Own Drugs (PODs) Version.: 2.2 Effective From: 20 January 2016 Expiry Date: 20 January 2019 Date Ratified: 13 January 2016 Ratified
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Animals on Hospital Premises Policy Version No. 6.0 Effective From: 16 March 2018 Expiry Date: 16 March 2021 Date Ratified: 06 March 2018 Ratified
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Key Control Operational Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Key Control Operational Policy Version.: 1.0 Effective From: 18 January 2016 Expiry Date: 18 January 2019 Date Ratified: 22 December 2015 Ratified
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Employment Policies and Procedures. Breastfeeding Supporting Staff Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Employment Policies and Procedures Breastfeeding Supporting Staff Policy Version No.: 2.1 Effective From: 20 June 2018 Expiry Date: 30 June 2020 Date
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Patient Choice Directive Policy & Guidance
The Newcastle upon Tyne Hospitals NHS Foundation Trust Patient Choice Directive Policy & Guidance Version No.: 2.1 Effective From: 26 August 2014 Expiry Date: 26 August 2016 Date Ratified: 17 June 2014
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Named Key Worker for Cancer Patients Policy Version No.: 4 Effective 07 December 2017 From: Expiry Date: 07 December 2020 Date Ratified: 17 October
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:
More informationThe Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy
The Newcastle upon Tyne NHS Hospitals Foundation Trust Version No.: 4.2 Effective From: 27 October 2015 Expiry Date: 27 October 2018 Date Ratified: 1 July 2015 Ratified By: Clinical Risk Group 1 Introduction
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients
The Newcastle upon Tyne Hospitals NHS Foundation Trust Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients Version.: 2.0 Effective From: 15 March 2018 Expiry Date: 15 March
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Ventilation Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Ventilation Policy Version.: 1.0 Effective From: 15 January 2016 Expiry Date: 15 January 2019 Date Ratified: 22 December 2015 Ratified By: Estates
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care
The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for Monitoring of Delayed Transfers of Care Version No.: 2.2 Effective From: 17 March 2015 Expiry Date: 17 March 2018 Date Ratified: 25
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Strategy for Non-Medical Prescribing Version No: 2.2 Effective From: 19 October 2016 Expiry Date: 19 October 2019 Date Ratified: 12 October 2016 Ratified
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Protected Mealtime Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Protected Mealtime Policy Version No 3 Effective From 12 February 2018 Expiry date 12 February 2021 Date Ratified 01 November 2017 Ratified By Nutritional
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Safe and Effective Use of Bedrails
The Newcastle upon Tyne Hospitals NHS Foundation Trust Safe and Effective Use of Bedrails Version No.: 2.0 Effective From: 31 October 2017 Expiry Date: 31 October 2020 Date Ratified: 24 July 2017 Ratified
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Visitors Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Visitors Policy Version No. 1.1 Effective From 18 th October 2012 Expiry Date 30 th September 2015 Date Ratified 14 th September 2012 Ratified By
More informationPHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives
PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Injectable Medicines Policy Version No.: 4.3 Effective From: 24 March 2017 Expiry Date: 21 January 2019 Date Ratified: 11 January 2017 Ratified By:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Central Alert System (CAS) Policy and Procedure
The Newcastle upon Tyne Hospitals NHS Foundation Trust Central Alert System (CAS) Policy and Procedure Version No.: 4.1 Effective From: 6 August 2013 Expiry Date: 6 August 2016 Date Ratified: 2 August
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-Operative Marking
The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-Operative Marking Version.: 6.1 Effective From: 01 April 2015 Expiry Date: 01 April 2018 Date Ratified: 17 December 2014 Ratified By: Theatre
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Advice and Guidance on Workplace Temperatures for all Trust Employees
The Newcastle upon Tyne Hospitals NHS Foundation Trust Advice and Guidance on Workplace Temperatures for all Trust Employees Version No.: 3.2 Effective From: 20 March 2018 Expiry Date: 20 March 2021 Date
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. First Aid Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust First Aid Policy Version No.: 5.0 Effective From: 23 January 2014 Expiry Date: 23 January 2017 Date Ratified: 7 th November 2013 Ratified By: Trust
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Strategy for the Prevention of Slips, Trips and Falls
The Newcastle upon Tyne Hospitals NHS Foundation Trust Strategy for the Prevention of Slips, Trips and Falls Version No: 3.2 Effective From: 6 October 2016 Expiry Date: 7 July 2018 Date Ratified: 12 May
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Decontamination of Healthcare Equipment following Patient Use and Prior to Service or Repair
The Newcastle upon Tyne Hospitals NHS Foundation Trust Decontamination of Healthcare Equipment following Patient Use and Prior to Service or Repair Version No.: 5.0 Effective From: 27 December 2017 Expiry
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust Incidents, Accidents and the Trust Disciplinary Process - Guidelines for Managers, Clinical Directors and Employees Version.: 4.1 Effective From:
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Mandatory Training Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Version No.: 10.0 Effective Date: 1 st July 2012 Expiry Date: 30 th June 2015 Date Ratified: 6 th June 2012 Ratified By: Executive Team Mandatory
More informationExecutive Director of Nursing and Chief Operating Officer
Document Title Arrangements for Managing Patients Mental and Physical Health Needs across NTW and the Acute Hospital Trusts Reference Number Lead Officer Author(s) (name and designation) Ratified by NTW(C)15
More informationPolicy on Governance Arrangements Relating to Medicines V2.0
V2.0 August 2015 Summary. The policy outlines the governance arrangements for medicines within the Trust, specifically; 1. The committee structure in the Trust and the county for medicine related matters
More informationMedicines Reconciliation Policy
Medicines Reconciliation Policy Lead executive Medical Director Authors details Senior Clinical Pharmacy Technician - 01244 39 7494 Document level: Trustwide (TW) Code: MP19 Issue number: 3 Type of document
More informationCommissioning Policy (WM12) Patients Changing Responsible Commissioner. Version 2 February 2012
Commissioning Policy (WM12) Patients Changing Responsible Commissioner Version 2 February 2012 Version: 2.0 Ratified by (name of West Mercia Cluster Board and Worcestershire Clinical Committee): Senate
More informationBare Below the Elbow Supplementary Policy for Hand Hygiene
Bare Below the Elbow Supplementary Policy for Hand Hygiene 2.1 EQUALITY IMPACT The Trust strives to ensure equality of opportunity for all, both as a major employer and as a provider of health care. This
More informationConsultation on proposals to introduce independent prescribing by paramedics across the United Kingdom
Consultation on proposals to introduce independent prescribing by paramedics across the United Kingdom Reply Form (hard copy) This response form accompanies the main consultation document which is available
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust Advance Decision to Refuse Treatment Policy (Advanced Refusal of Treatment/ Previously known as Living Wills) Incorporating the Mental Capacity Act
More informationLoading Dose Worksheet for Oral Amiodarone
This applies to adult patients only Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Prescribe as per loading dose worksheet below End 1. Aim/Purpose of this Guideline 1.1.
More informationCARERS POLICY. All Associate Director of Patient Experience. Patient & Carers Experience Committee & Trust Management Committee
CARERS POLICY Department / Service: Originator: All Associate Director of Patient Experience Accountable Director: Chief Nursing Officer Approved by: Patient & Carers Experience Committee & Trust Management
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Standard Precautions Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Version.: 3.2 Effective From: 21 July 2015 Expiry date: 21 July 2018 Date Ratified: 10 July 2015 Ratified By: IPCC 1 Introduction Standard Precautions
More informationPolicy for Failure to Bring/Attend Children s Health Appointments Whittington Health 2012/2013
Policy for Failure to Bring/Attend Children s Health Appointments Whittington Health 2012/2013 Subject: Policy Number: 1 Ratified by: Policy for Failure to Bring/Attend and Cancellation of Children s Health
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust Radiation Safety Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Radiation Safety Policy Version No. 1.0 Effective from: 26 th May 2015 Expiry date: 26 th May 2017 Date ratified: 1 st March 2015 Ratified by: Radiation
More informationDate ratified November Review Date November This Policy supersedes the following document which must now be destroyed:
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationNMC programme of change for education Prescribing and standards for medicines management
NMC programme of change for education Prescribing and standards for medicines management This response form relates to our consultation on nurse and midwifery prescribing competency proposals, programme
More informationEqual Pay Statement and Gender Pay Gap Information
Equal Pay Statement and Information As at 31 st March 2017 1 Accessibility If you would like this document in alternative formats such as Braille, large print, audio or in a language of your choice, please
More informationDocument Title: Training Records. Document Number: SOP 004
Document Title: Training Records Document Number: SOP 004 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationAdministration of urinary catheter maintenance solution by a carer
Document level: Trustwide Code: CP71 Issue number: 1 Administration of urinary catheter maintenance solution by a carer Lead executive Director of Nursing Therapies Patient Partnership Authors details
More informationJOB DESCRIPTION. Lead Haematology/Chemotherapy Clinical Nurse Specialist Head of Nursing Medicine
JOB DESCRIPTION Job Title: Department: Medicine - Haematology Day Care Unit Reports to: Lead Haematology/Chemotherapy Clinical Nurse Specialist Head of Nursing Medicine Liaises with: Lead Haematology/Chemotherapy
More informationTRUST BOARD TB(16) 44. Summary of Lord Carter recommendations Operational productivity and performance in English acute hospitals
TRUST BOARD TB(16) 44 Title: Action: Meeting: Summary of Lord Carter recommendations Operational productivity and performance in English acute hospitals FOR NOTING Date of meeting Purpose: The purpose
More informationCLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline To provide guidance for appropriate referral to the acute pain service for in-patient review. 2. The Guidance PAIN SERVICES
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
overview bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view
More informationDiagnostic Testing Procedures in Urodynamics V3.0
V3.0 09 01 18 Table of Contents Summary.... 1. Introduction... 3 1.1. Diagnostic testing information... 3 2. Purpose of this Policy/Procedure... 3 2.1. Approved Document Process... 3 3. Scope... 3 3.1.
More informationIBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationClinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline
Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide anaesthetists with an algorithm to work with when dealing with
More informationTHE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST REDUCING HARM TISSUE VIABILITY PROGRESS REPORT
Agenda item A5(iv) THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST REDUCING HARM TISSUE VIABILITY PROGRESS REPORT EXECUTIVE SUMMARY The Tissue Viability Team assists wards and departments to reduce
More informationPerson/persons conducting this assessment with Contact Details Marilyn Rees Lead VTE Nurse ext 48729
Appendix 2 - Equality Impact Assessment - Thromboprophylaxis Policy for Adult In-Patients Section A: Assessment Name of Policy Thromboprophylaxis Policy for Adult In-Patients Person/persons conducting
More informationThe NMC equality diversity and inclusion framework
The NMC equality diversity and inclusion framework Introduction 1 The Nursing and Midwifery Council (NMC) is the independent professional regulator for nurses and midwives in the UK. We exist to protect
More informationPARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationPolicy for the Management of Safety Alerts issued via the Central Alerting System (CAS)
Policy for the Management of Safety Alerts issued via the Central Alerting System (CAS) Policy Title: Executive Summary: Policy for the Management of Safety Alerts issued via the Central Alerting System
More informationNew Clinical Interventional Procedures Policy
New Clinical Interventional Procedures Policy Policy Title: Executive Summary: New Clinical Interventional Procedures Policy This document sets out East Cheshire NHS Trust s policy to ensure compliance
More informationNURSES HOLDING POWER SECTION 5(4) MENTAL HEALTH ACT 1983 NOVEMBER 2015
NURSES HOLDING POWER SECTION 5(4) MENTAL HEALTH ACT 1983 NOVEMBER 2015 This policy supersedes all previous policies for Nurses Holding Power Section 5(4) MHA 1983. 1 Policy title Nurses Holding Power Section
More informationEquality Analysis. Halton and St Helens HSTH Equality Analysis Number (provided by the E&D Team)
Equality Analysis Division Service Name Equality Analysis Number (provided by the E&D Team) Directorate Service Lead Responsible for completion of Equality Analysis What is the aim of the service? What
More informationFramework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013
Framework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013 Information reader box NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information
More informationPositive and Safe Management of Post incident Support and Debrief. Ron Weddle Deputy Director, Positive and Safe Care
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Positive and Safe Management of Post incident Support and Debrief NTW(C)13 Ron Weddle Deputy Director, Positive
More informationEquality Act 2010 Compliance Report
Equality Act 2010 Compliance Report 2016-2017 The Public Sector Equality Duty The public sector Equality Duty (section 149 of the Act) came into force on 5 April 2011. The Equality Duty applies to public
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline aims to improve outcomes for patients presenting with sepsis or developing sepsis
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust Pressure Ulcer and Moisture Lesion Prevention and Treatment Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Pressure Ulcer and Moisture Lesion Prevention and Treatment Policy Version No: 1.2 Effective from: 27 December 2017 Expiry Date 01 August 2020 Date
More informationDiagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging
Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.
More informationReferral to Treatment (RTT) Access Policy
General Referral to Treatment (RTT) Access Policy This is a controlled document and whilst this document may be printed, the electronic version posted on the intranet/shared drive is the controlled copy.
More informationDischarge Policy for Paediatric Patients from the Children s Unit
Discharge Policy for Paediatric Patients from the Children s Unit Policy : Discharge Policy for Paediatric Patients from the Children s Unit Executive Summary Intended to work alongside the East Cheshire
More informationCLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS
CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline This guideline is to support the use of bed and chair sensor alarm
More informationStandard Operating Procedure for Orthopaedic Elective Admissions
Standard Operating Procedure for Orthopaedic Elective Admissions Version Number 5 Version Date February 2016 Procedure Owner Author First approval or date last reviewed Staff/Groups Consulted Director
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Exclusion from Treatment of Violent or Abusive Patients
The Newcastle upon Tyne Hospitals NHS Foundation Trust Exclusion from Treatment of Violent or Abusive Patients Version No.: 4.1 Effective From: 11 October 2016 Expiry Date: 11 October 2019 Date Ratified:
More informationDeciding Together: Equalities analysis for the in patient scenarios. NHS Newcastle Gateshead CCG
Deciding Together: Equalities analysis for the in patient scenarios NHS Newcastle Gateshead CCG Project title: Authors: Owner: Customer: Equalities analysis for the in patient scenarios Deciding Together
More informationCLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY
WORKING WITH THE PHARMACEUTICAL INDUSTRY Page 1 of 11 WORKING WITH THE PHARMACEUTICAL INDUSTRY CCG Policy Reference: SuttonCCG/SLCSU/GOV/099 THIS POLICY WILL BE APPROVED BY THE CLINICAL COMMISSIONING GROUP
More informationPolicy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0
Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0 January 2016 Summary. This policy applies only to selected staff within the Haematology Department at the
More informationNMC programme of change for education Prescribing and standards for medicines management
NMC programme of change for education Prescribing and standards for medicines management This response form relates to our consultation on nurse and midwifery prescribing competency proposals, programme
More informationConsultant to Consultant Referral Policy
Consultant to Consultant Referral Policy Version Author Date Comments Approved by No V1.0 Mel Sims 19 January 2017 To be APPROVED Governing Body Reader information Reference Document purpose COM002 This
More informationThis guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.
CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing
More informationPaediatric Observation and Assessment Unit Operational Policy
Paediatric Observation and Assessment Unit Operational Policy 1 Policy Title: Paediatric Observation and Assessment Unit Operational Policy Executive Summary: Supersedes: Description of Amendment(s): This
More informationCLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS
CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS RATIONALE All Professionals/healthcare workers are personally accountable for their practice and, in the exercise of their professional accountability,
More informationElectronic Prescription Service Release 2 Nomination Policy
Electronic Prescription Service Release 2 Nomination Policy Reference number: Version: Responsible Committee: Version 1.5 (Final) Clinical Executive, Quality and Improvement. Date approved: 10 th June
More informationSection 134 Mental Health Act 1983 Patients Correspondence
Section 134 Mental Health Act 1983 Patients Correspondence Lead executive Medical Director Authors details Mental Health Act Manager - 01244 393167 Document level: Trustwide (TW) Code: MH10 Issue number:
More informationAnimals and Pets in Healthcare Facilities Policy
Animals and Pets in Healthcare Facilities Policy Post holder responsible for Procedural Document Author of Guideline Division/ Department responsible for Procedural Document Contact details Judy Potter,
More informationGCP Training for Research Staff. Document Number: 005
GCP Training for Research Staff Document Number: 005 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationVersion: 2. Date adopted: 17 May publication: Review date: September Expiry date: March 2019
Pest Control Policy This policy outlines the arrangements of management of pests on and within Trust properties Key words: Pest, Control Version: 2 Adopted by: Quality Assurance Committee Date adopted:
More informationA list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Colposcopist within Colposcopy Dept. Royal Cornwall Hospital 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse Colposcopist
More informationEast Cheshire NHS Trust VitalPAC Business Continuity
East Cheshire NHS Trust VitalPAC Business Continuity Page 1 Document Title: Executive Summary: This plan provides clear instructions on Business Continuity when VitalPAC functions are unavailable Supersedes:
More informationAppendix 1. Policy on the Dissemination, Implementation and Monitoring of National Clinical Guidance
Appendix 1 Policy on the Dissemination, Implementation and Monitoring of National Clinical Guidance Policy Title: Executive Summary: Policy on the dissemination, implementation and monitoring of national
More informationDrainage of Abdominal Ascites
Drainage of Abdominal Ascites Standard Operating Procedure (SOP) Prepared by: Cancer & Vascular Access Advanced Nurse Practitioner Presented to: Date: Care and Clinical Policies Group 18 January 2017 Cancer
More informationWARD CLOSURE POLICY V
WARD CLOSURE POLICY V3.0 29.07.15 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 4 5.1.
More informationHealth and Safety Policy and Arrangements
Health and Safety Policy and Arrangements Version Control Version Date Authored by Description of Changes 1 Aug 2017 Neil Hawthorne Original draft 2 Jan 2018 Richard Marinelli Customisation to academy
More informationEquality Impact: Screening and Assessment Form
Equality Impact: Screening and Assessment Form Section 1: Policy details - policy is shorthand for any activity of the organisation and could include strategies, criteria, provisions, functions, practices
More informationBLOOD AND BODILY FLUID GUIDELINES
BLOOD AND BODILY FLUID GUIDELINES Version Number 3.1 Version Date January 2016 Policy Owner Author First approval or date last reviewed Staff/Groups Consulted Director of Infection Prevention and Control
More informationSTANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES
STANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES Issue History Issue Version Purpose of Issue/Description of Change
More information2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures.
Was Not Brought, Cancellation and Refusal of Appointments Policy for Children and Young People up to the Age of 18 Years (up to the age of 25 years for people with a Learning Disability) 1. Aim/Purpose
More information